Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Fuel Cell Catalyst Patents in USA

29 Jun 2017 07:00

RNS Number : 4579J
Ilika plc
29 June 2017
 

Ilika plc

("Ilika" or the "Company")

 

Grant of Fuel Cell Catalyst Patents in USA

 

Ilika (AIM: IKA), a pioneer in solid-state battery technology and materials innovation, announces the grant of three patents covering catalysts for hydrogen fuel cells in the USA. These patents cover a type of catalyst known as "Core-Shell Catalysts", where the catalyst is the coating on nano-scale spherical particles, like the hard shell on a golf ball.

 

Catalysts are key to ensuring the efficiency and reliability of fuel cells. The catalysts must therefore be stable in the aggressive acidic environment created within hydrogen fuel cells, whilst highly active in promoting the chemical reactions necessary for converting hydrogen and oxygen into electricity and water.

 

Core-Shell Nanostructured Catalysts typically have a relatively low-cost and stable core, which is then coated with a thin layer (shell) of the active catalyst. The Company's patented catalysts have mixed metal oxide (ceramic) cores covered in platinum. The three wholly owned granted patents were originally filed in January 2013. The Company had previously undertaken a joint development project with Toyota examining other catalyst materials which resulted in an earlier jointly-owned patent filing, which has since gone to grant in Japan and is currently being processed in other jurisdictions.

 

Commenting on the patents granted, Graeme Purdy, Ilika CEO, said: "Whilst our solid-state battery programme is our key focus, our materials discovery platform is generating innovative, patentable materials with a variety of applications. The pace of innovation in the automotive industry has never been greater as companies compete to develop increasingly more energy-efficient, low emission vehicles. While electrical hybrid vehicles using battery technology have captured the largest share of the low-emission market at this point and fully battery-powered electric vehicles are also seeing strong take-up, fuel cell vehicles offer the advantage of long driving range, which justifies the development of key technologies such as low-cost, robust catalysts."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Numis Securities Limited

Tel: 020 7260 1000

Oliver Cardigan/ Paul Gillam /

 

James Black

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

Notes to Editors

A fuel cell is an electrochemical conversion device that produces electricity without combustion of the fuel. Hydrogen is the most common energy supply for a fuel cell as it has the right electrochemistry and the exhaust product is water. Many fuel cells under development, particularly for transport and electronics applications, use platinum-based electrodes. While platinum works well, it is a very scarce element and therefore expensive. Membrane electrode assemblies, of which platinum is the principal cost, typically make up 40% of the cost of a fuel cell. The end-market for fuel cell technology is still in its infancy. However, the development of platinum-lean catalysts could significantly accelerate the development of this market. Several automotive companies, including Toyota and BMW, include fuel cell vehicles in their future road maps.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDUWRORBUANUAR
Date   Source Headline
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn
17th Nov 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.